Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Cushman & Wakefield: Hong Kong Retail Market in Gradual 1H Recovery Since Border Reopening, Office Leasing Market Yet to Stage Significant Rebound
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
Media-OutReach Newswire LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Media-OutReach Newswire Fosun Participates in the 3rd BEYOND Expo to Deepen Biotechnology Innovation and Global Development
Most human rights recommendations acceptable to Việt Nam, some need further consideration: Official 4.